Julia Lewtak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Julia Lewtak has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Kamil Syga
Stefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, Lublin, Poland
5 shared publications - Dawid Staniak
SP ZOZ MSWiA in Lublin, Poland
3 shared publications - Julia Szczepanowska-Sujka
Stefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, Lublin, Poland
3 shared publications - Katarzyna StęPniak
Stefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, Lublin, Poland
3 shared publications - Laura Starobrat
Stefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, Lublin, Poland
3 shared publications - Mateusz Szczepanik
Stefan Cardinal Wyszyński Provincial Specialist Hospital SPZOZ in Lublin, Lublin, Poland
3 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(52))
THE ROLE OF SOCIAL MEDIA IN MENTAL DISORDER SELF-DIAGNOSIS AMONG YOUNG ADULTS: A NARRATIVE REVIEW
Background: Social media makes mental health information readily accessible, but its contribution to self-diagnostic beliefs is not well established. Objective: To critically assess evidence relating exposure to mental health content on social media to self-diagnosis among young adults. Methods: This focused narrative review synthesized observational, experimental, qualitative, and review literature identified through PubMed/MEDLINE and publisher websites. Studies assessing viewers’ beliefs and behaviors were prioritized over content-only analyses. Results: Cross-sectional studies report associations between exposure and diagnostic self-attribution, but cannot establish temporal order. A randomized experiment involving 490 students found that misleading ADHD videos impaired factual knowledge while increasing confidence in that knowledge and some treatment-seeking intentions. Content analyses document misleading information; however, the proportion of misleading videos cannot be interpreted as the prevalence of incorrect self-diagnosis. Definitions differ substantially between studies, and prospective research tracing online exposure to subsequent clinical evaluation is limited. Conclusions: Social media can support recognition of difficulties and encourage questions about mental health, but may also amplify unwarranted diagnostic certainty. The available evidence does not demonstrate that routine platform use independently causes incorrect self-diagnosis. Distinguishing symptom recognition, suspected disorders, self-labelling, and clinical diagnosis is essential for research and practice.
- 11 November 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(52))
Open AccessTHE ROLE OF SOCIAL MEDIA IN MENTAL DISORDER SELF-DIAGNOSIS AMONG YOUNG ADULTS: A NARRATIVE REVIEW
Background: Social media makes mental health information readily accessible, but its contribution to self-diagnostic beliefs is not well established. Objective: To critically assess evidence relating exposure to mental health content on social media to self-diagnosis among young adults. Methods: This focused narrative review synthesized observational, experimental, qualitative, and review literature identified through PubMed/MEDLINE and publisher websites. Studies assessing viewers’ beliefs and behaviors were prioritized over content-only analyses. Results: Cross-sectional studies report associations between exposure and diagnostic self-attribution, but cannot establish temporal order. A randomized experiment involving 490 students found that misleading ADHD videos impaired factual knowledge while increasing confidence in that knowledge and some treatment-seeking intentions. Content analyses document misleading information; however, the proportion of misleading videos cannot be interpreted as the prevalence of incorrect self-diagnosis. Definitions differ substantially between studies, and prospective research tracing online exposure to subsequent clinical evaluation is limited. Conclusions: Social media can support recognition of difficulties and encourage questions about mental health, but may also amplify unwarranted diagnostic certainty. The available evidence does not demonstrate that routine platform use independently causes incorrect self-diagnosis. Distinguishing symptom recognition, suspected disorders, self-labelling, and clinical diagnosis is essential for research and practice.
- Open Access
- 30 October 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(52))
DERMATOLOGICAL MISINFORMATION IN THE DIGITAL AGE: SOCIAL MEDIA, PATIENT TRUST, SELF-DIAGNOSIS, AND TREATMENT DECISION-MAKING – A CRITICAL NARRATIVE REVIEW
Background: Social media platforms are increasingly used as sources of information and advice regarding acne, psoriasis, photoprotection, and skin care. The reliability of available content varies considerably, and its popularity does not necessarily reflect its scientific quality. Objective: To critically evaluate the available evidence on the nature of dermatological misinformation, the credibility of its sources, patient trust, and the potential influence of online health information on self-diagnosis and treatment decision-making. Methods: A narrative review of original studies and review articles was conducted, primarily using literature identified through PubMed/MEDLINE. The review included social media content analyses, questionnaire-based studies, and experimental research investigating interventions aimed at counteracting misinformation. Results: Available studies demonstrate substantial variability in the quality of dermatological information shared on social media platforms, with a considerable proportion of content produced by individuals without medical qualifications. Survey findings confirm that patients frequently seek and use online health advice. However, the observed associations do not establish a direct causal relationship between exposure to misinformation and objectively measured treatment outcomes. Conclusions: Improving patient education, strengthening physician–patient communication, and conducting prospective studies are essential to addressing dermatological misinformation. Future research should distinguish between exposure to online content, subsequent treatment decisions, and objectively documented clinical harm.
- 30 October 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(52))
Open AccessDERMATOLOGICAL MISINFORMATION IN THE DIGITAL AGE: SOCIAL MEDIA, PATIENT TRUST, SELF-DIAGNOSIS, AND TREATMENT DECISION-MAKING – A CRITICAL NARRATIVE REVIEW
Background: Social media platforms are increasingly used as sources of information and advice regarding acne, psoriasis, photoprotection, and skin care. The reliability of available content varies considerably, and its popularity does not necessarily reflect its scientific quality. Objective: To critically evaluate the available evidence on the nature of dermatological misinformation, the credibility of its sources, patient trust, and the potential influence of online health information on self-diagnosis and treatment decision-making. Methods: A narrative review of original studies and review articles was conducted, primarily using literature identified through PubMed/MEDLINE. The review included social media content analyses, questionnaire-based studies, and experimental research investigating interventions aimed at counteracting misinformation. Results: Available studies demonstrate substantial variability in the quality of dermatological information shared on social media platforms, with a considerable proportion of content produced by individuals without medical qualifications. Survey findings confirm that patients frequently seek and use online health advice. However, the observed associations do not establish a direct causal relationship between exposure to misinformation and objectively measured treatment outcomes. Conclusions: Improving patient education, strengthening physician–patient communication, and conducting prospective studies are essential to addressing dermatological misinformation. Future research should distinguish between exposure to online content, subsequent treatment decisions, and objectively documented clinical harm.
- Open Access
- 30 October 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(52))
PRESERVING AND RESTORING SENSATION AFTER NIPPLE SPARING MASTECTOMY THROUGH NERVE PRESERVATION AND NIPPLE AREOLAR COMPLEX NEUROTIZATION
Preserving the nipple–areolar complex during mastectomy does not ensure that its sensory function is retained. This narrative review evaluates nerve preservation and nipple–areolar complex neurotization, distinguishing objective sensory recovery from patient-reported benefit and surgical safety. A focused PubMed search was performed, supplemented by targeted searches for anatomical, methodological, and reconstructive publications and review of available full texts. The synthesis included clinical series, comparative studies, a small randomized conference report, anatomical investigations, and relevant consensus publications, without quantitative pooling. Early implant-based reconstruction studies reported encouraging recovery of tactile sensibility, but several lacked concurrent controls. Comparative observational evidence suggests potential psychosocial and sexual well-being benefits, although reconstruction type and treatment selection complicate causal interpretation. A six-patient randomized split-chest report did not demonstrate significant sensory differences, emphasizing the preliminary nature of the evidence. Larger matched database research provides reassurance regarding recorded postoperative complications but does not establish sensory efficacy or oncologic equivalence. Assessment methods vary substantially, encompassing pressure thresholds, two-point discrimination, and patient-reported measures. Nerve preservation and neurotization are promising components of functional breast reconstruction, provided that they do not alter the required oncologic resection. Standardized baseline and longitudinal assessment, adequately powered comparative studies, and transparent counseling are needed before the magnitude, durability, and generalizability of benefit can be established.
- 30 October 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(52))
Open AccessPRESERVING AND RESTORING SENSATION AFTER NIPPLE SPARING MASTECTOMY THROUGH NERVE PRESERVATION AND NIPPLE AREOLAR COMPLEX NEUROTIZATION
Preserving the nipple–areolar complex during mastectomy does not ensure that its sensory function is retained. This narrative review evaluates nerve preservation and nipple–areolar complex neurotization, distinguishing objective sensory recovery from patient-reported benefit and surgical safety. A focused PubMed search was performed, supplemented by targeted searches for anatomical, methodological, and reconstructive publications and review of available full texts. The synthesis included clinical series, comparative studies, a small randomized conference report, anatomical investigations, and relevant consensus publications, without quantitative pooling. Early implant-based reconstruction studies reported encouraging recovery of tactile sensibility, but several lacked concurrent controls. Comparative observational evidence suggests potential psychosocial and sexual well-being benefits, although reconstruction type and treatment selection complicate causal interpretation. A six-patient randomized split-chest report did not demonstrate significant sensory differences, emphasizing the preliminary nature of the evidence. Larger matched database research provides reassurance regarding recorded postoperative complications but does not establish sensory efficacy or oncologic equivalence. Assessment methods vary substantially, encompassing pressure thresholds, two-point discrimination, and patient-reported measures. Nerve preservation and neurotization are promising components of functional breast reconstruction, provided that they do not alter the required oncologic resection. Standardized baseline and longitudinal assessment, adequately powered comparative studies, and transparent counseling are needed before the magnitude, durability, and generalizability of benefit can be established.
- Open Access
- 21 July 2026
- Published by Medical Communications Sp. z.o.o. in Aktualności Neurologiczne
- Vol. 26 (1) , 34
Analysis of potentially modifiable risk factors for amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis, also referred to as sclerosis lateralis amyotrophica, motor neuron disease, or Lou Gehrig’s disease, is a rare neurodegenerative disorder that causes progressive degeneration of both upper and lower motor neurons. It is a terminal condition and the most common form of motor neuron disease. Its global prevalence is estimated as 1.68 per 100,000 persons. Although its exact causes remain unclear, numerous probable risk factors have been identified. This paper aims to expand knowledge about these potentially modifiable factors. The most common theories postulate an association between the disorder and exposure to toxins and alcohol use, smoking, traumatic brain injuries, a history of electric shock, and viral infections (for example, those caused by enteroviruses). Moreover, a lower body mass index is considered a factor worsening the course of amyotrophic lateral sclerosis due to decreased fat deposits in underweight individuals, which cannot compensate for lower energy intake and higher energy expenditure in individuals with this disorder. Conversely, appropriate control of systolic hypertension, as well as the use of antihypertensive drugs, such as perindopril, may be regarded as protective factors. A better understanding of these factors could help implement more effective preventive measures, which could potentially lower the incidence of amyotrophic lateral sclerosis.
- 21 July 2026
- Published by Medical Communications Sp. z.o.o. in Aktualności Neurologiczne
- Vol. 26 (1) , 34
Open AccessAnalysis of potentially modifiable risk factors for amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis, also referred to as sclerosis lateralis amyotrophica, motor neuron disease, or Lou Gehrig’s disease, is a rare neurodegenerative disorder that causes progressive degeneration of both upper and lower motor neurons. It is a terminal condition and the most common form of motor neuron disease. Its global prevalence is estimated as 1.68 per 100,000 persons. Although its exact causes remain unclear, numerous probable risk factors have been identified. This paper aims to expand knowledge about these potentially modifiable factors. The most common theories postulate an association between the disorder and exposure to toxins and alcohol use, smoking, traumatic brain injuries, a history of electric shock, and viral infections (for example, those caused by enteroviruses). Moreover, a lower body mass index is considered a factor worsening the course of amyotrophic lateral sclerosis due to decreased fat deposits in underweight individuals, which cannot compensate for lower energy intake and higher energy expenditure in individuals with this disorder. Conversely, appropriate control of systolic hypertension, as well as the use of antihypertensive drugs, such as perindopril, may be regarded as protective factors. A better understanding of these factors could help implement more effective preventive measures, which could potentially lower the incidence of amyotrophic lateral sclerosis.
- Open Access
- 29 June 2026
- Published by Poznan University of Medical Sciences in Journal of Medical Science
- Vol. 95 (2) , e1565
Emerging Therapies in Multiple Sclerosis Management – Can We Stop the Demyelinating Process?
Introduction. Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system (CNS) characterised by neuroinflammation and neurodegeneration leading to progressive disability. Its complex immunopathogenesis involves autoreactive T cells, B cells, and myeloid cells, with growing evidence highlighting the pivotal role of B lymphocytes. B cells contribute through antigen presentation, cytokine secretion, autoantibody production, and formation of ectopic lymphoid structures, making them key therapeutic targets. Current disease-modifying therapies (DMTs), including anti-CD20 monoclonal antibodies such as ocrelizumab, ofatumumab, and recently launched ublituximab, have significantly improved clinical outcomes. However, optimisation of long-term efficacy and safety remains challenging. The novel agent, frexalimab, which targets the CD40–CD40L pathway, aims to refine treatment precision and safety further.Material and methods. A systematic search of PubMed, Scopus, and Web of Science (October–November 2025) was conducted to identify clinical trials and high-quality reviews on emerging MS therapies, with emphasis on anti-CD20 agents, BTK inhibitors, frexalimab, and CAR-T therapy. Eligible studies were critically appraised for mechanisms of action, clinical efficacy, safety, and relevance, with particular focus on recent phase II–III data.Results. This review synthesises current insights into MS immunopathology and recent advances in B-cell-targeted therapies and CAR-T approaches, highlighting an evolving therapeutic landscape focused on improving disease control and long-term outcomes.Conclusions. Continued development of targeted immunotherapies may bring the field closer to sustained remission, effective prevention of progression, and potentially enhanced CNS repair.
- 29 June 2026
- Published by Poznan University of Medical Sciences in Journal of Medical Science
- Vol. 95 (2) , e1565
Open AccessEmerging Therapies in Multiple Sclerosis Management – Can We Stop the Demyelinating Process?
Introduction. Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system (CNS) characterised by neuroinflammation and neurodegeneration leading to progressive disability. Its complex immunopathogenesis involves autoreactive T cells, B cells, and myeloid cells, with growing evidence highlighting the pivotal role of B lymphocytes. B cells contribute through antigen presentation, cytokine secretion, autoantibody production, and formation of ectopic lymphoid structures, making them key therapeutic targets. Current disease-modifying therapies (DMTs), including anti-CD20 monoclonal antibodies such as ocrelizumab, ofatumumab, and recently launched ublituximab, have significantly improved clinical outcomes. However, optimisation of long-term efficacy and safety remains challenging. The novel agent, frexalimab, which targets the CD40–CD40L pathway, aims to refine treatment precision and safety further.Material and methods. A systematic search of PubMed, Scopus, and Web of Science (October–November 2025) was conducted to identify clinical trials and high-quality reviews on emerging MS therapies, with emphasis on anti-CD20 agents, BTK inhibitors, frexalimab, and CAR-T therapy. Eligible studies were critically appraised for mechanisms of action, clinical efficacy, safety, and relevance, with particular focus on recent phase II–III data.Results. This review synthesises current insights into MS immunopathology and recent advances in B-cell-targeted therapies and CAR-T approaches, highlighting an evolving therapeutic landscape focused on improving disease control and long-term outcomes.Conclusions. Continued development of targeted immunotherapies may bring the field closer to sustained remission, effective prevention of progression, and potentially enhanced CNS repair.
- Open Access
- 8 May 2025
- Published by Institute of Rural Health in Annals of Agricultural and Environmental Medicine
- Vol. 32 (4) , 566-571
Epidemiological characteristics of treated multiple sclerosis patients – Lublin experience (South-Eastern Poland)
Introduction and objective: Multiple sclerosis (MS) is one of the most common neurological diseases affecting about 2.8 million people worldwide. The aim of this study is to analyze the current MS patient population in Lublin, south-east Poland, to enhance understanding of disease risk and...
- 8 May 2025
- Published by Institute of Rural Health in Annals of Agricultural and Environmental Medicine
- Vol. 32 (4) , 566-571
Open AccessEpidemiological characteristics of treated multiple sclerosis patients – Lublin experience (South-Eastern Poland)
Introduction and objective: Multiple sclerosis (MS) is one of the most common neurological diseases affecting about 2.8 million people worldwide. The aim of this study is to analyze the current MS patient population in Lublin, south-east Poland, to enhance understanding of disease risk and...
- Open Access
- 25 April 2024
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
Congenital tracheobronchial branching anomalies – types and clinical significance.
Introduction and objective: Objective.The tracheobronchial tree consists of the pathways through which air reaches the pulmonary alveoli. Anomalies in the tracheobronchial tree can be both congenital and acquired. Congenital anomalies include tracheal bronchus, accessory cardiac bronchus, lung...
- 25 April 2024
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
Open AccessCongenital tracheobronchial branching anomalies – types and clinical significance.
Introduction and objective: Objective.The tracheobronchial tree consists of the pathways through which air reaches the pulmonary alveoli. Anomalies in the tracheobronchial tree can be both congenital and acquired. Congenital anomalies include tracheal bronchus, accessory cardiac bronchus, lung...